Waeber Bernard, Volpe Massimo, Ruilope Luis M, Schmieder Roland E
Division of Pathophysiology, Centre Hospitalier Universitaire Vaudois and University of Lausanne , Lausanne , Switzerland.
Blood Press. 2014 Aug;23(4):193-9. doi: 10.3109/08037051.2013.854946. Epub 2013 Nov 15.
Hypertension resistant to lifestyle interventions and antihypertensive medications is a common problem encountered by physicians in everyday practice. It is most often defined as a blood pressure remaining ≥ 140/90 mmHg despite the regular intake of at least three drugs lowering blood pressure by different mechanisms, one of them being a diuretic. It now appears justified to include, unless contraindicated or not tolerated, a blocker of the renin-angiotensin system and a calcium channel blocker in this drug regimen, not only to gain antihypertensive efficacy, but also to prevent or regress target organ damage and delay the development of cardiorenal complications. A non-negligible fraction of treatment-resistant hypertension have normal "out of office" blood pressures. Ambulatory blood pressure monitoring and/or home blood pressure recording should therefore be routinely performed to identify patients with true resistant hypertension, i.e. patients who are more likely to benefit from treatment intensification.
对生活方式干预和降压药物治疗有抵抗的高血压是医生在日常临床实践中经常遇到的问题。它通常被定义为尽管规律服用至少三种通过不同机制降压的药物(其中一种为利尿剂),血压仍持续≥140/90 mmHg。现在看来,在这种药物治疗方案中,除非有禁忌或不耐受情况,加入肾素 - 血管紧张素系统阻滞剂和钙通道阻滞剂是合理的,这不仅能提高降压效果,还能预防或逆转靶器官损害,并延缓心肾并发症的发生。相当一部分治疗抵抗性高血压患者在“非诊室”状态下血压正常。因此,应常规进行动态血压监测和/或家庭血压记录,以识别真正的抵抗性高血压患者,即更有可能从强化治疗中获益的患者。